- Home
- GVH vs ACON Comparison
GVH vs ACON Comparison
Compare GVH & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GVH | ACON |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 3.0M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GVH | ACON |
|---|---|---|
| Price | $1.10 | $2.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $80.00 | $23.00 |
| AVG Volume (30 Days) | ★ 2.8M | 96.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $102,768.97 | $71.77 |
| Revenue Next Year | N/A | $80.52 |
| P/E Ratio | $0.74 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $0.61 |
| 52 Week High | $10.74 | $21.31 |
Technical Indicators
Market Signals| Indicator | GVH | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 32.58 |
| Support Level | $0.88 | $2.34 |
| Resistance Level | $1.80 | $7.98 |
| Average True Range (ATR) | 0.17 | 0.20 |
| MACD | 0.07 | 0.07 |
| Stochastic Oscillator | 32.10 | 25.49 |
Price Performance
Historical ComparisonAbout GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.